These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Health technology assessment in Catalonia: an overview of past and future perspectives. de Solà-Morales O; Granados A Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():88-93. PubMed ID: 19519981 [TBL] [Abstract][Full Text] [Related]
23. The evolution of modern technology and its societal impact on biocommunications in academe. Singarella T J Biocommun; 1998; 25(1):2-11. PubMed ID: 9565852 [TBL] [Abstract][Full Text] [Related]
24. [Current status and future prospects for specializing in surgery in united Europe]. Gruwez JA; Pohland CC Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():822-31. PubMed ID: 9931732 [TBL] [Abstract][Full Text] [Related]
25. Psychiatry in eastern Europe today: mental health status, policies, and practices. Neumann J Am J Psychiatry; 1991 Oct; 148(10):1386-9. PubMed ID: 1897621 [TBL] [Abstract][Full Text] [Related]
26. Health technology assessment: what is it? Current status and perspectives in the field of electrophysiology. Fattore G; Maniadakis N; Mantovani LG; Boriani G Europace; 2011 May; 13 Suppl 2():ii49-53. PubMed ID: 21518750 [TBL] [Abstract][Full Text] [Related]
27. Foundational issues in risk assessment and risk management. Aven T; Zio E Risk Anal; 2014 Jul; 34(7):1164-72. PubMed ID: 24152111 [TBL] [Abstract][Full Text] [Related]
28. Science, politics, and the GM debate in Europe. Tencalla F Regul Toxicol Pharmacol; 2006 Feb; 44(1):43-8. PubMed ID: 16188360 [TBL] [Abstract][Full Text] [Related]
29. The Nuclear Medicine Technologist in Europe - current status and future perspective. van den Broek WJ Nucl Med Rev Cent East Eur; 2003; 6(2):135-7. PubMed ID: 14737729 [No Abstract] [Full Text] [Related]
30. Demystifying central review boards: current options and future directions. Levine RJ; Lasagna L IRB; 2000; 22(6):1-9. PubMed ID: 11883483 [No Abstract] [Full Text] [Related]
31. [Epidemiology of contact allergy in Europe: current situation and outlook for the future]. Uter W Actas Dermosifiliogr; 2011 Jan; 102(1):4-7. PubMed ID: 21315856 [No Abstract] [Full Text] [Related]
32. Futurescapes: expectations in Europe for relative effectiveness evidence for drugs in 2020. Towse A; Garau M; Mohr P; Messner DA J Comp Eff Res; 2015 Aug; 4(4):401-18. PubMed ID: 25740283 [TBL] [Abstract][Full Text] [Related]
33. Health technology assessment of asthma disease management programs. Steuten L; Lemmens K; Vrijhoef B Curr Opin Allergy Clin Immunol; 2007 Jun; 7(3):242-8. PubMed ID: 17489042 [TBL] [Abstract][Full Text] [Related]
34. Genetic testing and counselling in Europe: health professionals current educational provision, needs assessment and potential strategies for the future. Coviello DA; Skirton H; Ceratto N; Lewis C; Kent A Eur J Hum Genet; 2007 Dec; 15(12):1203-4. PubMed ID: 17895901 [No Abstract] [Full Text] [Related]
35. Health technology assessment for medical devices in Europe. What must be considered. Siebert M; Clauss LC; Carlisle M; Casteels B; de Jong P; Kreuzer M; Sanghera S; Stokoe G; Trueman P; Lang AW; Int J Technol Assess Health Care; 2002; 18(3):733-40. PubMed ID: 12391964 [TBL] [Abstract][Full Text] [Related]
36. Bacille Calmette-Guérin vaccination: the current situation in Europe. Dara M; Acosta CD; Rusovich V; Zellweger JP; Centis R; Migliori GB; Eur Respir J; 2014 Jan; 43(1):24-35. PubMed ID: 24381321 [No Abstract] [Full Text] [Related]
37. The educational and professional status of clinical embryology and clinical embryologists in Europe. Kovačič B; Plas C; Woodward BJ; Verheyen G; Prados FJ; Hreinsson J; De los Santos MJ; Magli MC; Lundin K; Plancha CE Hum Reprod; 2015 Aug; 30(8):1755-62. PubMed ID: 26071417 [TBL] [Abstract][Full Text] [Related]
38. Implant dentistry education in Europe: 5 years after the Association for Dental Education in Europe consensus report. Koole S; Vandeweghe S; Mattheos N; De Bruyn H Eur J Dent Educ; 2014 Mar; 18 Suppl 1():43-51. PubMed ID: 24484519 [TBL] [Abstract][Full Text] [Related]
39. Does conditional approval for new oncology drugs in Europe lead to differences in health technology assessment decisions? Lipska I; Hoekman J; McAuslane N; Leufkens HG; Hövels AM Clin Pharmacol Ther; 2015 Nov; 98(5):489-91. PubMed ID: 26250656 [TBL] [Abstract][Full Text] [Related]
40. A history of health technology assessment at the European level. Banta D; Kristensen FB; Jonsson E Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():68-73. PubMed ID: 19534837 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]